Announcements Trials
Browse Landscape

Phase

Phase 2 43Phase NA 24Phase 1 21Phase 3 14Phase 1/2 5Phase 2/3 1

Status

Completed 27Terminated 16Recruiting 13Withdrawn 11Unknown 8Active not recruiting 5Not yet recruiting 2

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

CNS 3Thoracic 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Brain Neoplasms 2Stomach Neoplasms 1Prostatic Neoplasms 1Ovarian Neoplasms 1Meningioma 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 69Nivolumab 39Cyclophosphamide 35Carboplatin 27Dexamethasone 23Specimen Handling 22Paclitaxel 22Lenalidomide 22durvalumab 20Radiotherapy 19Gemcitabine 19venetoclax 18Magnetic Resonance Spectroscopy 18Doxorubicin 17Rituximab 16Ipilimumab 16fludarabine 15Bevacizumab 15Biopsy 14atezolizumab 13Etoposide 13Vincristine 12Cisplatin 12Azacitidine 12belantamab mafodotin 11Pemetrexed 11Docetaxel 11Calcium Dobesilate 11olaparib 10Oxaliplatin 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1/2 × Active not recruiting × Radiosurgery × Clear all
NCT02696993 2026-05-20

Nivolumab and Radiation Therapy With or Without Ipilimumab in Treating Patients With Brain Metastases From Non-small Cell Lung Cancer

M.D. Anderson Cancer Center

Phase 1/2 Active not recruiting
80 enrolled
CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT03604978 2026-05-13

Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma

National Cancer Institute (NCI)

Phase 1/2 Active not recruiting
38 enrolled
CNS

Meningioma

NCT04194554 2026-05-01

ASCLEPIuS

University of Michigan Rogel Cancer Center

Phase 1/2 Active not recruiting
102 enrolled
Genitourinary

Prostatic Neoplasms

NCT03508752 2026-03-27

Neurocognitive Decline in Patients With Brain Metastases

University of Texas Southwestern Medical Center

Phase 1/2 Active not recruiting
80 enrolled
CNS

Brain Neoplasms

NCT06940921 2025-04-27

SBRT-LDRT-Cadonilimab for Advanced Gastric, Colorectal and Ovarian Cancers With Peritoneal Metastases

First Affiliated Hospital of Chongqing Medical University

Phase 1/2 Active not recruiting
26 enrolled
GastrointestinalGynecologic

Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡